Targeted therapies in breast cancer /

The development of monoclonal antibodies and other inhibitors of specific molecules, fully utilizing the insights learned from molecular techniques such as comparative microarrays and protein expression patterns, has led to the development and FDA approval of several agents for the treatment of brea...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Burstein, Harold J.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press, ©2011.
Colección:Oxford American pocket notes.
Temas:
Breast > Cancer > Treatment > Handbooks, manuals, etc.
Drug targeting > Handbooks, manuals, etc.
Drug Delivery Systems
Breast Neoplasms > drug therapy
Sein > Cancer > Traitement > Guides, manuels, etc.
Médicaments > Ciblage > Guides, manuels, etc.
HEALTH & FITNESS > Diseases > Cancer.
MEDICAL > Oncology.
Breast > Cancer > Treatment
Drug targeting
Handbooks and manuals
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover; Table of Contents; Introduction; Antiestrogen Therapies; Aromatase Inhibitors (AI's); Selective Estrogen Receptor Modulators (SERM's) and Estrogen-Receptor Downregulators (ERD's); Chemotherapeutic Agents-Microtubule Targeting Agents; Taxanes; Ixabepilone; Eribulin Mesylate; HER2 Directed Therapies for Metastatic Breast Cancer; Trastuzumab; Trastuzumab-Refactory Breast Cancer; Investigational Agents; HER2 Directed Therapy for Early Stage Breast Cancer; Angiogenesis Inhibitors in Breast Cancer; Bevacizumab; VEGFR Inhibitors; PARP Inhibitors; Emerging Areas; References.

Ejemplares similares